Document is current
Any future updates will be listed below
-
Authors
Elfgen, Anne
Hupert, Michelle
Bochinsky, Kevin
Tusche, Markus https://orcid.org/0000-0003-0530-7469
González de San Román Martin, Estibaliz
Gering, Ian
Sacchi, Silvia https://orcid.org/0000-0002-2338-2561
Pollegioni, Loredano https://orcid.org/0000-0003-1733-7243
Huesgen, Pitter F. https://orcid.org/0000-0002-0335-2242
Hartmann, Rudolf https://orcid.org/0000-0001-7807-6273
Santiago-Schübel, Beatrix
Kutzsche, Janine
Willbold, Dieter https://orcid.org/0000-0002-0065-7366
- License Information
-
More Information
Article History
Received: 5 June 2018
Accepted: 20 March 2019
First Online: 5 April 2019
Competing Interests
: D.W. is co-inventor of patents covering the composition of matter of RD2, which was used in the present study. D.W. is also co-founder and co-owner of the company “Priavoid GmbH”, which is developing RD2 further for clinical use. This did not have influence on any data evaluation or its interpretation. All other authors declare no competing interests.
